| [1] |
Bashour FN, Teran JC, Mullen KD. Prevalence of peripheral blood cytopenias (hypersplenism) in patients with nonalcoholic chronic liver disease[J]. Am J Gastroenterol, 2000, 95(10):2936-2939.
|
| [2] |
曹金铎．脾脏外科[M]．北京：人民卫生出版社，2002:316-317.
|
| [3] |
Ren S, Zhang S, Li M, et al. NF-κB p65 and c-Rel subunits promote phagocytosis and cytokine secretion by splenic macrophages in cirrhotic patients with hypersplenism[J]. Int J Biochem Cell Biol, 2013, 45(2):335-343.
|
| [4] |
Jiang A, Zhang S, Li Z, et al. miR-615-3p promotes the phagocytic capacity of splenic macrophages by targeting ligand-dependent nuclear receptor corepressor in cirrhosis-related portal hypertension[J]. Exp Biol Med, 2011, 236(6):672-680.
|
| [5] |
王国良，范建高．临床脾脏病学[M]．北京：人民卫生出版社，2005:267-268.
|
| [6] |
Bazeboso JA, Tshilolo LM, Mbongo CL, et al. Partial splenic embolization in a child with sickle cell disease and hypersplenism[J]. J Vasc Interv Radiol, 2016, 27(11):1738-1739.
|
| [7] |
Ozdil B, Akkiz H, Sandikci M, et al. Recurrent hypersplenism caused by giant accessory spleen due to portal hypertension after splenectomia[J]. Platelets, 2010, 21(1):70-71.
|
| [8] |
Kiani MA, Forouzan A, Masoumi K, et al. Isolated splenic vein thrombosis: 8-year-old boy with massive upper gastrointestinal bleeding and hypersplenism[J]. Case Rep Pediatr, 2015:480507.
|
| [9] |
Rajekar H, Vasishta RK, Chawla YK, et al. Noncirrhotic portal hypertension[J]. J Clin Exp Hepatol, 2011, 1(2):94-108.
|
| [10] |
Tang Y, Lu W, Zhang Z, et al. Hypersplenism: an independent risk factor for myocardial remodeling in chronic heart failure patients[J]. Int J Clin Exp Med, 2015, 8(4):5197-5206.
|
| [11] |
Ingle SB, Hinge Ingle CR. Primary splenic lymphoma: current diagnostic trends[J]. World J Clin Cases, 2016, 4(12):385-389.
|
| [12] |
Camba L, Aldrighetti L, Ciceri F, et al. Locoregional intrasplenic chemotherapy for hypersplenism in myelofibrosis[J]. Br J Haematol, 2001, 114(3):638-640.
|
| [13] |
Buzelé R, Barbier L, Sauvanet A, et al. Medical complications following splenectomy[J]. J Visc Surg, 2016, 153(4):277-286.
|
| [14] |
Anguita E, Candel FJ, González-Del Castillo J, et al. Splenectomy in ITP: we keep removing a healthy functional organ[J]. Ann Hematol, 2016, 95(11):1911-1912.
|
| [15] |
Cavazzana M, Antoniani C, Miccio A. Gene therapy for β-hemoglobinopathies[J]. Mol Ther, 2017, 25(5):1142-1154.
|
| [16] |
Lv X, Yang F, Guo X, et al. Hypersplenism is correlated with increased risk of hepatocellular carcinoma in patients with post-hepatitis cirrhosis[J]. Tumour Biol, 2016, 37(7):8889-8900.
|
| [17] |
Duan YQ, Liang P. Thermal ablati on for partial splenectomy hemostasis, spleen trauma, splenic metastasis and hypersplenism[J]. Hepatogastroenterology, 2013, 60(123):501-506.
|
| [18] |
Lavrenkov K, Krepel-Volsky S, Levi I, et al. Low dose palliative radiotherapy for splenomegaly in hematologic disorders[J]. Leuk Lymphoma, 2012, 53(3):430-434.
|
| [19] |
Martins GL, Bernardes JP, Rovella MS, et al. Radiofrequency ablation for treatment of hypersplenism: a feasible therapeutic option[J]. World J Gastroenterol, 2015, 21(20):6391-6397.
|
| [20] |
Wang YB, Zhang JY, Zhang F, et al. Partial splenic artery embolization to treat hypersplenism secondary to hepatic cirrhosis: a meta-analysis[J]. Am Surg, 2017, 83(3):274-283.
|
| [21] |
Singh AK, Shankar S, Gervais DA, et al. Image-guided percutaneous splenic interventions[J]. Radiographics, 2012, 32(2):523-534.
|